Skip to main content
. 2017 Dec 27;41(4):680–687. doi: 10.2337/dc17-0534

Figure 1.

Figure 1

Diabetes outcomes during the WHI DMT. A: Diabetes progression for the DMT participants, exclusive of women with diabetes at randomization. The reduced risk for insulin initiation, from randomization to first report of insulin, for intervention-group women (T2, HR 0.74) is shown in the component outcomes: T1, time from randomization to first report of pills for diabetes (HR 0.95), and T3, time from pills to first report of insulin (HR 0.82). B: Progression from oral agents to insulin for DMT participants with diabetes and taking oral agents at baseline.